Stylianos Panopoulos

1.3k total citations
46 papers, 722 citations indexed

About

Stylianos Panopoulos is a scholar working on Pathology and Forensic Medicine, Rheumatology and Epidemiology. According to data from OpenAlex, Stylianos Panopoulos has authored 46 papers receiving a total of 722 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Pathology and Forensic Medicine, 13 papers in Rheumatology and 12 papers in Epidemiology. Recurrent topics in Stylianos Panopoulos's work include Systemic Sclerosis and Related Diseases (26 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (10 papers) and Inflammatory Myopathies and Dermatomyositis (10 papers). Stylianos Panopoulos is often cited by papers focused on Systemic Sclerosis and Related Diseases (26 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (10 papers) and Inflammatory Myopathies and Dermatomyositis (10 papers). Stylianos Panopoulos collaborates with scholars based in Greece, United States and United Kingdom. Stylianos Panopoulos's co-authors include Petros P. Sfikakis, Maria G. Tektonidou, Vasiliki-Kalliopi Bournia, Sophie Mavrogeni, Kalliopi Fragiadaki, George Konstantonis, Genovefa Kolovou, George D. Kitas, Spiros D. Ladas and Dimitrios Vassilopoulos and has published in prestigious journals such as International Journal of Molecular Sciences, Annals of the Rheumatic Diseases and Lara D. Veeken.

In The Last Decade

Stylianos Panopoulos

44 papers receiving 711 citations

Peers

Countries citing papers authored by Stylianos Panopoulos

Since Specialization

Citations

This map shows the geographic impact of Stylianos Panopoulos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stylianos Panopoulos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stylianos Panopoulos more than expected).

Fields of papers citing papers by Stylianos Panopoulos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stylianos Panopoulos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stylianos Panopoulos. The network helps show where Stylianos Panopoulos may publish in the future.

Co-authorship network of co-authors of Stylianos Panopoulos

This figure shows the co-authorship network connecting the top 25 collaborators of Stylianos Panopoulos. A scholar is included among the top collaborators of Stylianos Panopoulos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stylianos Panopoulos. Stylianos Panopoulos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Diurnal production of cortisol and prediction of treatment response in rheumatoid arthritis: a 6-month, real-life prospective cohort study 2024 ·RMD Open ·Maria P. Yavropoulou, (unknown), Nikolaos I. Vlachogiannis, G. Fragoulis, Katerina Laskari, Aimilia Mantzou, Stylianos Panopoulos, Antonis Fanouriakis, Vasiliki-Kalliopi Bournia, Gerasimos Evangelatos, Angeliki Papapanagiotou, Maria G. Tektonidou, George P. Chrousos, Petros P. Sfikakis	5
2	Presenting clinical and imaging features of patients with clinically amyopathic interstitial lung disease associated with myositis-specific autoantibodies 2024 ·Frontiers in Medicine ·Vasilios Tzilas, Argyrios Tzouvelekis, (unknown), Stylianos Panopoulos, Evangelos Bouros, (unknown), Jay H. Ryu, Demosthenes Bouros	2
3	Tocilizumab plus Nintedanib for progressive interstitial lung disease in systemic sclerosis: a one-year observational study 2024 ·Rheumatology International ·Stylianos Panopoulos, Vasilios Tzilas, Vasiliki-Kalliopi Bournia, Maria G. Tektonidou, Petros P. Sfikakis	2
4	Outcomes of COVID-19 re-infections: a single-center cohort of 167 patients with systemic rheumatic diseases 2024 ·Rheumatology International ·(unknown), G. Fragoulis, Aikaterini Arida, (unknown), Gerasimos Evangelatos, (unknown), Evrydiki Kravvariti, Katerina Laskari, Maria Mylona, (unknown), Nikolaos Papazoglou, Μαρία Παππά, (unknown), Stylianos Panopoulos, (unknown), (unknown), Maria G. Tektonidou, Petros P. Sfikakis	0
5	Chronological Age and DNA Damage Accumulation in Blood Mononuclear Cells: A Linear Association in Healthy Humans after 50 Years of Age 2023 ·International Journal of Molecular Sciences ·Nikolaos I. Vlachogiannis, (unknown), Μαρία Παππά, Evrydiki Kravvariti, Evangelia Georgia Kostaki, (unknown), (unknown), (unknown), Vasiliki-Kalliopi Bournia, Stylianos Panopoulos, Katerina Laskari, Aikaterini Arida, Vassilis G. Gorgoulis, Maria G. Tektonidou, Dimitrios Paraskevis, Petros P. Sfikakis, Vassilis L. Souliotis	1
6	Generic and disease-adapted cardiovascular risk scores as predictors of atherosclerosis progression in SLE 2023 ·Lupus Science & Medicine ·Stylianos Panopoulos, George C Drosos, George Konstantonis, Petros P. Sfikakis, Maria G. Tektonidou	13
7	Cardiopulmonary exercise testing and prognosis in patients with systemic sclerosis without baseline pulmonary hypertension: a prospective cohort study 2021 ·Rheumatology International ·Vasiliki-Kalliopi Bournia, Anastasios Kallianos, Stylianos Panopoulos, Elias Gialafos, (unknown), Panayiotis G. Vlachoyiannopoulos, Petros P. Sfikakis, Georgia Trakada	7
8	Increased influenza vaccination rates in patients with autoimmune rheumatic diseases during the Covid-19 pandemic: a cross-sectional study 2021 ·Rheumatology International ·G. Fragoulis, (unknown), (unknown), Aikaterini Arida, (unknown), Gerasimos Evangelatos, Kalliopi Fragiadaki, Αναστάσιος Καραμανάκος, Evrydiki Kravvariti, Stylianos Panopoulos, Μαρία Παππά, Κonstantinos Thomas, Maria G. Tektonidou, Dimitrios Paraskevis, Dimitrios Vassilopoulos, Petros P. Sfikakis	14
9	Anti-interleukin 6 Therapy Effect for Refractory Joint and Skin Involvement in Systemic Sclerosis: A Real-world, Single-center Experience 2021 ·The Journal of Rheumatology ·Stylianos Panopoulos, Maria G. Tektonidou, Vasiliki-Kalliopi Bournia, Aikaterini Arida, Petros P. Sfikakis	7
10	COVID-19 vaccine safety and nocebo-prone associated hesitancy in patients with systemic rheumatic diseases: a cross-sectional study 2021 ·Rheumatology International ·G. Fragoulis, (unknown), (unknown), Gerasimos Evangelatos, Kalliopi Fragiadaki, Αναστάσιος Καραμανάκος, (unknown), Katerina Laskari, Stylianos Panopoulos, Μαρία Παππά, Dimos D. Mitsikostas, Maria G. Tektonidou, Dimitrios Vassilopoulos, Petros P. Sfikakis	34
11	Comparable or higher prevalence of comorbidities in antiphospholipid syndrome vs rheumatoid arthritis: a multicenter, case-control study 2020 ·Lara D. Veeken ·Stylianos Panopoulos, Κonstantinos Thomas, Georgios Georgiopoulos, Dimitrios T. Boumpas, Christina Katsiari, George Βertsias, Alexandros A. Drosos, Kyriaki Boki, Theodoros Dimitroulas, Alexandros Garyfallos, Charalampos Papagoras, Pelagia Katsimbri, (unknown), Christina Adamichou, Evripidis Kaltsonoudis, (unknown), (unknown), Petros P. Sfikakis, Dimitrios Vassilopoulos, Maria G. Tektonidou	26
12	Treatment modalities and drug survival in a systemic sclerosis real-life patient cohort 2020 ·Arthritis Research & Therapy ·Stylianos Panopoulos, Katerina Chatzidionysiou, Maria G. Tektonidou, Vasiliki Kalliopi Bournia, Alexandros A. Drosos, Stamatis‐Nick C. Liossis, Theodoros Dimitroulas, Lazaros I. Sakkas, Dimitrios T. Boumpas, Paraskevi V. Voulgari, Dimitrios Daoussis, Κonstantinos Thomas, Georgios Georgiopoulos, (unknown), Alexandros Garyfallos, Prodromos Sidiropoulos, George Βertsias, Dimitrios Vassilopoulos, Petros P. Sfikakis	14
13	Prevalence of comorbidities in systemic sclerosis versus rheumatoid arthritis: a comparative, multicenter, matched-cohort study 2018 ·Arthritis Research & Therapy ·Stylianos Panopoulos, Maria G. Tektonidou, Alexandros A. Drosos, Stamatis‐Nick C. Liossis, Theodoros Dimitroulas, Alexandros Garyfallos, Lazaros I. Sakkas, Dimitrios T. Boumpas, Paraskevi V. Voulgari, Dimitrios Daoussis, Κonstantinos Thomas, Georgios Georgiopoulos, (unknown), Dimitrios Vassilopoulos, Petros P. Sfikakis	29
14	The 5-HT1A receptor agonist buspirone improves esophageal motor function and symptoms in systemic sclerosis: a 4-week, open-label trial 2016 ·Arthritis Research & Therapy ·George Karamanolis, Stylianos Panopoulos, (unknown), (unknown), (unknown), Dimitrios Kamberoglou, Spiros D. Ladas, Petros P. Sfikakis	36
15	Pseudo-infarction pattern in diffuse systemic sclerosis. Evaluation using cardiovascular magnetic resonance 2016 ·International Journal of Cardiology ·Sophie Mavrogeni, Georgia Karabela, Λουκία Κουτσογεωργοπούλου, Efthymios Stavropoulos, Gikas Katsifis, Sotiris C. Plastiras, George D. Kitas, Stylianos Panopoulos, (unknown), Eleni Tzatzaki, George Markousis‐Mavrogenis, Genovefa Kolovou, Petros P. Sfikakis	14
16	Clinical Queries Addressed in Patients with Systemic Autoimmune Diseases. Can Cardiovascular Magnetic Resonance Give the Final Solution? 2015 ·Inflammation & Allergy - Drug Targets ·Sophie Mavrogeni, Georgia Karabela, Elias Gialafos, (unknown), (unknown), Maria Mylona, Stylianos Panopoulos, (unknown), Genovefa Kolovou, Efthymios Stavropoulos, Maria Boutsikou, George D. Kitas, Petros P. Sfikakis	2
17	Mycophenolate Versus Cyclophosphamide for Progressive Interstitial Lung Disease Associated with Systemic Sclerosis: A 2-Year Case Control Study 2013 ·Lung ·Stylianos Panopoulos, (unknown), Georgia Trakada, (unknown), (unknown), Petros P. Sfikakis	40
18	Abnormal spatial QRS-T angle, a marker of ventricular repolarisation, predicts serious ventricular arrhythmia in systemic sclerosis. 2012 ·PubMed ·(unknown), (unknown), Christina Voulgari, (unknown), Stylianos Panopoulos, George Vaiopoulos, Myron Mavrikakis, Ioannis Moyssakis, Petros P. Sfikakis	13
19	Autochthonous Plasmodium vivax malaria in a Greek schoolgirl of the Attica region 2012 ·Malaria Journal ·(unknown), Konstantina Tzanetou, Ioannis Kotsantis, Stylianos Panopoulos, (unknown)	12
20	Biological treatments and connective tissue disease associated interstitial lung disease 2011 ·Current Opinion in Pulmonary Medicine ·Stylianos Panopoulos, Petros P. Sfikakis	48

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact